DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0020608 | Hypodontia | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C0678222 | Breast Carcinoma | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C1306459 | Primary malignant neoplasm | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C0278622 | Adult Malignant Peripheral Nerve Sheath Tumor | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C0751690 | Malignant Peripheral Nerve Sheath Tumor | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C0006142 | Malignant neoplasm of breast | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C3714524 | Fibromyxosarcoma | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C0452138 | Sensorineural hearing loss, bilateral | CHSY1 | 22856 | chondroitin sulfate synthase 1 | Q86X52 |
C0020473 | Hyperlipidemia | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0006142 | Malignant neoplasm of breast | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0011849 | Diabetes Mellitus | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0020456 | Hyperglycemia | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0011847 | Diabetes | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0030567 | Parkinson Disease | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0016751 | Hereditary fructose intolerance syndrome | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C0268435 | Renal Tubular Acidosis, Type II | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C0400966 | Non-alcoholic Fatty Liver Disease | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C0162557 | Liver Failure, Acute | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C0009402 | Colorectal Carcinoma | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C2711227 | Steatohepatitis | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C0038356 | Stomach Neoplasms | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C2239176 | Liver carcinoma | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C0009806 | Constipation | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
C0029823 | Other specified peritonitis | ALDOB | 229 | aldolase, fructose-bisphosphate B | P05062 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024